Sarcoidosis: historical perspective and immunopathogenesis (Part I). (Q48003748)

7 February 2018

review article

1 reference

title

Sarcoidosis: historical perspective and immunopathogenesis (Part I). (English)

1 reference

7 February 2018

1 reference

7 February 2018

author name string

Müller-Quernheim J

series ordinal

1 reference

7 February 2018

publication date

1 February 1998

1 reference

7 February 2018

published in

Respiratory Medicine

1 reference

7 February 2018

volume

1 reference

7 February 2018

issue

1 reference

7 February 2018

page(s)

126-139

1 reference

7 February 2018

Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Detection of mycobacterial rRNA in sarcoidosis with liquid-phase hybridisation

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

"Tastes great, less filling". The debate about mycobacteria and sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Mycobacterial nucleic acids in sarcoid lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Epidemiology of sarcoidosis in the Isle of Man--1: A case controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Investigation of a unique time-space cluster of sarcoidosis in firefighters

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Sarcoidosis in nurses: is there an association?

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Transmission of sarcoidosis via cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Could Borrelia burgdorferi be a causal agent of sarcoidosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Anti-Borrelia burgdorferi immunoglobulin seroprevalence in pulmonary sarcoidosis: a negative report

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Serological response to Chlamydia pneumoniae in patients with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

The Kveim test in sarcoidosis. A study of 750 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Chemical inactivation of the Kveim reagent

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Stimulation of bronchoalveolar lavage (BAL) and blood lymphocytes by Kveim antigen, tuberculin and concanavalin A in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

In vitro culture of leukocytes from patients with sarcoidosis: In search of an “in vitro Kveim test”

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Anti-Kveim monoclonal antibody. New monoclonal antibody reacting to epithelioid cells in sarcoid granulomas

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Bronchopulmonary Lavage in Normal Subjects and Patients with Obstructive Lung Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Bronchoalveolar lavage in interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Ultrastructural alterations of the air-blood barrier in sarcoidosis and hypersensitivity pneumonitis and their relation to lung histopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Structural features of interstitial lung disease in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Glucose, K+, and albumin concentrations in the alveolar milieu of normal humans and pulmonary sarcoidosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Effect of interstitial lung disease macrophages on T-cell signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Augmentation of rat alveolar macrophage migration by surfactant protein

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Pulmonary sarcoidosis: Assessment of disease activity by lung lymphocyte subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

T lymphocytes compartmentalized on the epithelial surface of the lower respiratory tract express the very late activation antigen complex VLA-1

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Interleukin-2 receptor gene expression by bronchoalveolar lavage lymphocytes in pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

T-lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of the T-cell antigen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Characterization of bronchoalveolar lymphocytes during a specific antibody-forming cell response in the lungs of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Lack of immune deficiency in sarcoidosis: compartmentalisation of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Alveolar epithelial cells block lymphocyte proliferation in vitro without inhibiting activation

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Impaired G-proteins and cyclic nucleotide phosphodiesterase activity in T-lymphocytes from patients with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Nonviable autologous bronchoalveolar lavage cell preparations induce intradermal epithelioid cell granulomas in sarcoidosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Bias toward use of a specific T cell receptor beta-chain variable region in a subgroup of individuals with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Selective activation and accumulation of oligoclonal V beta-specific T cells in active pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Preferential Usage of the T-Cell Antigen Receptor β-Chain Constant Region Cβ1 Element by Lung T-Lymphocytes of Patients with Pulmonary Sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

TCR V beta families in T cell clones from sarcoid lung parenchyma, BAL, and blood

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

T cell receptor repertoire of T lymphocytes recovered from the lung and blood of patients with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Limited heterogeneity of biased T-cell receptor V beta gene usage in lung but not blood T cells in active pulmonary sarcoidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Human TH1 and TH2 subsets: doubt no more

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Spontaneous production of various cytokines except IL-4 from CD4+ T cells in the affected organs of sarcoidosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Th1/Th2 cell distribution in pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Increased numbers of T lymphocytes with gamma delta-positive antigen receptors in a subgroup of individuals with pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Increased gamma/delta-positive T-cells in blood and bronchoalveolar lavage of patients with sarcoidosis and hypersensitivity pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

T-lymphocytes with gamma delta+ V delta 2+ antigen receptors are present in increased proportions in a fraction of patients with tuberculosis or with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Clonal expansion of lung V delta 1+ T cells in pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Gamma/Delta T-Lymphocytes Are Not Increased in Number in Granulomatous Lesions of Patients with Tuberculosis or Sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

T cell receptor V beta gene bias in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

T cell antigen receptor V gene usage. Increases in V beta 8+ T cells in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Phenotypic markers of alveolar macrophage maturation in pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Lung-restricted Activation of the Alveolar Macrophage/Monocyte System in Pulmonary Sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Effect of GM-CSF on TNF-alpha and IL-1-beta production by alveolar macrophages and peripheral blood monocytes from patients with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Evaluation of alveolar macrophages in normals and individuals with active pulmonary sarcoidosis for the spontaneous expression of the interleukin-1 beta gene

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Interleukin-1 receptor antagonist expression in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

IL-1 and IL-1 inhibitory activity in the culture supernatants of alveolar macrophages from patients with interstitial lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Increased interleukin 6 production by bronchoalveolar lavage cells in patients with active sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Cachectin: more than a tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Production of cytokines in sarcoid lymph nodes: preferential expression of interleukin-1 beta and interferon-gamma genes

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Detection of endogenous cytokines in sera or in lymph nodes obtained from patients with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Mononuclear Cells in Human Lung Parenchyma: Characterization of a Potent Accessory Cell Not Obtained by Bronchoalveolar Lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

The alveolar macrophage

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Antigen presentation by alveolar macrophages in patients with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Induction of accessory cell function of human alveolar macrophages by inhalation of human natural interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation?

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Release of superoxide anion by alveolar macrophages in pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Increased release of free oxygen radicals by phagocytosing and nonphagocytosing cells from patients with active pulmonary sarcoidosis as revealed by luminol-dependent chemiluminescence

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Enhanced chemiluminescence response of phagocyting monocytes from sarcoidosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Hydrogen peroxide release by alveolar macrophages from sarcoid patients and by alveolar macrophages from normals after exposure to recombinant interferons alpha A, beta, and gamma and 1,25-dihydroxyvitamin D3.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Increased number of alveolar macrophages expressing surface molecules of the CD11/CD18 family in sarcoidosis and idiopathic pulmonary fibrosis is related to the production of superoxide anions by these cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Increased levels of oxidized methionine residues in bronchoalveolar lavage fluid proteins from patients with idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Pathogenetic significance of reactive oxygen species in diffuse fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

ICAM-1 and integrin expression on isolated human alveolar type II pneumocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Expression of class II major histocompatibility complex antigens on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Idiopathic pulmonary fibrosis: cellular and molecular pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Role of mesenchymal cell death in lung remodeling after injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Inflammatory and immunomodulatory roles of TGF-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Th1 and Th2 in human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Role of transforming growth factor-βthe preferential induction of T helper cells of type 1 by staphylococcal enterotoxin B

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

Effect of anti-CD3/anti-CD28/interleukin-2 stimulation of mononuclear cells on transforming growth factor beta inhibition of lymphokine-activated killer cell generation.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990085-3

7 January 2021

10.1016/S0954-6111(98)90085-3

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018